ruthenium has been researched along with etoposide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista, AA; Beraldo, H; Fagundes, ES; Graminha, AE; Rodrigues, C; Teixeira, LR | 1 |
| Chao, H; Huang, H; Ji, L; Qiao, L; Wang, J; Zhang, P | 1 |
| Aldrich-Wright, JR; Ng, NS; Wu, MJ | 1 |
3 other study(ies) available for ruthenium and etoposide
| Article | Year |
|---|---|
Ruthenium(II) complexes of 2-benzoylpyridine-derived thiosemicarbazones with cytotoxic activity against human tumor cell lines.
Topics: Antineoplastic Agents; Benzyl Compounds; Cell Death; Cell Line, Tumor; Cell Proliferation; Colchicine; Drug Screening Assays, Antitumor; Electrochemistry; Etoposide; Humans; Magnetic Resonance Spectroscopy; Pyridines; Ruthenium; Spectrophotometry, Infrared; Thiosemicarbazones | 2008 |
Chiral ruthenium(II) complexes with phenolic hydroxyl groups as dual poisons of topoisomerases I and IIα.
Topics: Apoptosis; Camptothecin; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Chemistry, Pharmaceutical; Comet Assay; DNA; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Drug Design; Drug Screening Assays, Antitumor; Etoposide; Humans; Inhibitory Concentration 50; Protein Binding; Ruthenium; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2013 |
The cytotoxicity of some phenanthroline-based antimicrobial copper(II) and ruthenium(II) complexes.
Topics: Anti-Infective Agents; Apoptosis; Catalase; Cell Adhesion; Cell Line; Cell Survival; Cisplatin; Coordination Complexes; Copper; Enterococcus faecalis; Etoposide; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Kidney; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutagens; Phenanthrolines; Reactive Oxygen Species; Ruthenium; Staphylococcus aureus | 2018 |